Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2).
Bioorg Med Chem Lett
; 18(3): 973-8, 2008 Feb 01.
Article
em En
| MEDLINE
| ID: mdl-18182289
ABSTRACT
We report herein the initial exploration of novel selective HDAC1/HDAC2 inhibitors (SHI-12). Optimized SHI-12 structures exhibit enhanced intrinsic activity against HDAC1 and HDAC2, and are greater than 100-fold selective versus other HDACs, including HDAC3. Based on the SAR of these agents and our current understanding of the HDAC active site, we postulate that the SHI-12 extend the existing HDAC inhibitor pharmacophore to include an internal binding domain.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Derivados de Benzeno
/
Modelos Moleculares
/
Inibidores de Histona Desacetilases
Tipo de estudo:
Prognostic_studies
Limite:
Humans
Idioma:
En
Revista:
Bioorg Med Chem Lett
Assunto da revista:
BIOQUIMICA
/
QUIMICA
Ano de publicação:
2008
Tipo de documento:
Article
País de afiliação:
Estados Unidos